Possible role of nitric oxide in the antinociceptive action of intraventricular bradykinin in mice

European Journal of Pharmacology

Volumn 310, Issue 2-3, 1996, Pages 123-127

  Germany, Aniza ^a   González, Paulo ^a   Contreras, Enrique ^a  

^a UNIVERSITY OF CONCEPCIÓN   (Chile)

Author keywords

Antinociception; Bradykinin; N(G) Nitro L arginine; Nitric oxide (NO)

Indexed keywords

ARGININE; BRADYKININ; METHYLENE BLUE; MORPHINE; N(G) NITROARGININE; NALOXONE; NITRIC OXIDE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; HOT PLATE TEST; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030605960     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(96)00384-6     Document Type: Article

References (23)

1. Argiolas, A., M.R. Melis and G.L. Gessa, 1985, Bradykinin antagonizes morphine-induced analgesia in rats, Eur. J. Pharmacol. 112, 277.
2. Bauer, M.B., M.L. Simons, S. Murphy and G.F. Gebhart, 1993, Bradykinin and capsaicin stimulate cyclic GMP production in cultured dorsal root ganglion neurons via a nitrosyl intermediate, J. Neurosci. Res. 36, 280.
3. Duarte, I.D.G. and S.H. Ferreira, 1992, The molecular mechanism of central analgesia induced by morphine on carbachol and the L-arginine-nitric oxide-cGMP pathway, Eur. J. Pharmacol. 221, 171.
4. Eddy, N.B. and D.J. Leimbach, 1953, Synthetic analgesics II dithienylbutenyl and dithienylbutyl amines, J. Pharmacol. Exp. Ther. 107, 385.
5. Haley T.J. and W.G. McCormick, 1957, Pharmacological effects produced by intra cerebral injections of drugs in conscious mouse, Br. J. Pharmacol. 12, 12.
6. Haley, J.E., A.H. Dickenson and M. Schachter, 1989, Electrophysiological evidence for a role of bradykinin in chemical nociception in the rat, Neurosci. Lett. 97, 198.
7. Haley, J.E., A.H. Dickenson and M. Schachter, 1992, Electro-physiological evidence for a role of nitric oxide in prolonged chemical nociception in the rat, Neuropharmacology 31, 251.
8. Harvey, J.S. and G.N. Burgess, 1993, A nitric oxide synthase inhibitor reduces desensitization of bradykinin-induced activation of phospholipase C in sensory neurons, Trans. Biochem. Soc. 21, 4355.
9. Hirsch, D.B., J.P. Steiner, T.M. Dawson, A. Mammen, E. Hayek and S.H. Snyder, 1993, Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synapsotomes, Current Biol. 3, 749.
10. Kawabata, A. and H. Takagi, 1994, The dual role of L-arginine in nociceptive processing in the brain: involvement of nitric oxide and kyotorphin, in: Nitric Oxide - Roles in Neuronal Communication and Neurotoxicity, eds. H. Takagi, N. Toda and R.D. Hawkins (Japan Scientific Societies Press, Tokyo, and CRC Press, USA) p. 115.
11. Kawabata, A., Y. Fukuzumi, Y. Fukushima and H. Takagi, 1992, antmociceptive effect of L-arginine on the carrageenin-induced hyperalgesia of the rat: possible involvement of central opiopeptidergic systems, Eur. J. Pharmacol. 218, 153.
12. Laneuville, O. and R. Couture, 1987, Bradykinin analogue blocks bradykinin-induced inhibition of a spinal nociceptive reflex in the rat, Eur. J. Pharmacol. 137, 281.
13. Laneuville, O., T.A. Reader and R. Couture, 1989, Intrathecal bradykinin acts presynaptically on spinal noradrenergic terminals to produce anlinociception in the rat, Eur. J. Pharmacol. 159, 273.
14. Martin, H.A.. A.I. Basbaum, G.C. Kwiat, E.J. Goetzl and J.D. Levine, 1987, Leukotriene and prostaglandin sensitization of cutaneous high-threshold C-and A-delta mechanonociceptors in the hairy skin of rat hindlimbs, Neuroscience 22, 651.
15. Mayer, B., F. Brunner and K. Schmidt, 1993, Inhibition of nitric oxide synthesis by methylene blue, Biochem. Pharmacol. 45, 367.
16. McGhee, D.S., M.F. Goy and G.S. Oxford, 1992, Involvement of nitric oxide-cyclic GMP pathways in the desensitization of bradykinin responses of cultured rat sensory neurons, Neuron 9, 315.
17. G-nitroarginine methyl ester exhibits antinociceptive activity in the mouse, Br. J. Pharmacol. 102, 192.
18. Rees, D.D., R.M.J. Palmer, H.F. Hodson and S. Moncada, 1989, A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation, Br. J. Pharmacol. 96, 418.
19. Reeh, P., 1986, Sensory receptors in mammalian skin in an in vitro preparation, Neurosci. Lett. 66, 141.
20. Ribeiro, S.A., A.P. Corrado and F.G. Graeff, 1971, Antinociceptive action of intraventricular bradykinin, Neuropharmacology 10, 725.
21. Steranka, L.R., D.C. Manning, C.J. DeHaas, J.W. Ferkany, S.A. Borosky, J.R. Connor, R.J. Vavrek, J.M. Stewart and S.H. Snyder, 1988, Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions, Proc. Natl. Acad. Sci. USA 85, 3245.
22. Tseng, L.F., J.Y. Xu and G.M. Pieper, 1992, Increase of nitric oxide production by L-arginine potentiates i.c.v. administered β-endorphininduced antinociception in the mouse, Eur. J. Pharmacol. 212, 301.
23. Winter, C.A. and L. Flataker, 1950, Studies on heptazone (6-morpholino-4,4-diphenyl-3-amino heptanone hydrochloride) in comparison with other analgesic drugs, 1950, J. Pharmacol. Exp. Ther. 98, 305.